Drug Trial Radar · NCT03214367
A Study of LY900014 in Participants With Type 1 Diabetes
Last checked: Nov 20, 2026Latest source record: May 1, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,392
Actual
Start
Jul 17, 2017
Primary completion
Sep 6, 2018
Study completion Aug 22, 2019
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jul 11, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy of the study drug LY900014 compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in adults with type 1 diabetes (T1D).
Conditions
- Type 1 Diabetes Mellitus
Interventions
LY900014Drug
Administered SC
Insulin LisproDrug
Administered SC
Insulin GlargineDrug
Administered SC
Insulin DegludecDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hemoglobin A1c (HbA1c) Efficacy Estimand at Week 26Time frame: Baseline, Week 26
Locations
172 sites in 20 countries. Site status is shown where the registry gives one.
Internal Medicine Center LLC
Mobile, Alabama
John Muir Physician Network Clinical Research Center
Concord, California
AMCR Institute INC
Escondido, California
Valley Endocrine, Fresno
Fresno, California
Marin Endocrine Associates
Greenbrae, California
Diabetes and Endocrine Associates
La Mesa, California
University Clinical Investigators, Inc.
Tustin, California
Coastal Metabolic Research Centre
Ventura, California
Barbara Davis Center for Childhood Diabetes
Aurora, Colorado
The Center For Diabetes & Endocrine Care
Fort Lauderdale, Florida
East Coast Institute For Research
Jacksonville, Florida
Sun Coast Clinical Research, Inc
New Port Richey, Florida
Metabolic Research Institute Inc.
West Palm Beach, Florida
Atlanta Diabetes Associates
Atlanta, Georgia
East Coast Institute For Research
Macon, Georgia
Endocrine Research Solutions, Inc.
Roswell, Georgia
East West Medical Institute
Honolulu, Hawaii
Northwest Clinical Trials
Boise, Idaho
Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho
Prairie Education and Research Cooperative
Springfield, Illinois
Iderc, P.L.C.
West Des Moines, Iowa
University of Kansas Medical Center
Kansas City, Kansas
Cotton O'Neil Diabetes and Endocrinology Center
Topeka, Kansas
Kentucky Diabetes Endocrinology Center
Lexington, Kentucky
MassResearch
Waltham, Massachusetts
Palm Research Center
Las Vegas, Nevada
Palm Research Center
Las Vegas, Nevada
Southern New Hampshire Diabetes and Endocrinology
Nashua, New Hampshire
Manhattan Medical Research
New York, New York
Physicians East
Greenville, North Carolina
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina
PMG Research of Wilmington, LLC
Wilmington, North Carolina
Your Diabetes Endocrine Nutrition Group PC
Mentor, Ohio
Lehigh Valley Hospital
Allentown, Pennsylvania
Partners in Nephrology & Endocrinology
Pittsburgh, Pennsylvania
Sudir Bansal M.D. Inc.
Warwick, Rhode Island
University Diabetes and Endocrine Consultants
Chattanooga, Tennessee
Texas Diabetes and Endocrinology
Austin, Texas
Dallas Diabetes Endocrine Center
Dallas, Texas
Texas Diabetes and Endocrinology, P.A.
Round Rock, Texas
Showing 40 of 172 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.